Javascript must be enabled to continue!
The Onc Docs: Partnering with Black cancer patients for cancer education.
View through CrossRef
e18681 Background: In 2022, there will be approximately 224,080 new cancer cases and 73,680 cancer deaths among Black individuals in the United States. Black people are disproportionately burdened by cancer due to higher incidence and mortality levels across multiple cancer types. Yet, their stories are underrepresented in media and the top podcasts for cancer education do not feature Black experts. We formed our podcast, The Onc Docs, to highlight the (under-told) stories of Black individuals with cancer and to provide education about cancer from Black patient survivors, patient advocates and oncologists.We sought to understand the current landscape of podcasts focused on the Black cancer experience & to assess public engagement with The Onc Docs across social media platforms. Methods: We conducted a search of "Black cancer" in Google, Spotify and Apple podcasts. Search engines were also utilized to identify podcasts with a focus on the Black cancer experience. Finally, we reviewed our publicly available listener and follower statistics. Results: At least 12 podcasts on the Black cancer experience were identified with the majority available on Google Podcasts. Seven of the twelve podcasts focused on breast cancer in Black women while two podcasts discussed prostate cancer and one featured brain tumors. Two podcasts (17%) published episodes for one or more years. The remaining podcasts (n = 10) were in existence for an average of 3 months. Three podcasts had published an episode in 2022. Since starting our podcast in September 2020, we have 958 Twitter followers and 400 followers on Instagram. According to Spotify, from 2021-2022, our podcast was heard in 4 countries, increased 87% in streams, 40% in listeners and 235% in hours spent listening to our episodes. On Google Podcasts, we have 4 subscribers. Each month, about 100 unique visitors navigate to our website. Conclusions: Podcasts on the Black cancer experience are needed especially those with a focus apart from breast cancer. Prior podcasts may lack longevity due to a lack of financial and infrastructural support needed to sustain a podcast. In the past year, our work has garnered attention from the general public and gained traction with patient advocacy and scientific associations like Black in Cancer, Cancer Research UK, and Touch Breast Cancer. However, additional efforts & support are needed to ensure consistent creation and delivery of episodes. For instance, we can utilize Facebook, the largest social media platform, to expand our reach. With future growth, we will be able to access data analytic tools to determine the demographic breakdown of our audience and if we are reaching Black listeners.
American Society of Clinical Oncology (ASCO)
Title: The Onc Docs: Partnering with Black cancer patients for cancer education.
Description:
e18681 Background: In 2022, there will be approximately 224,080 new cancer cases and 73,680 cancer deaths among Black individuals in the United States.
Black people are disproportionately burdened by cancer due to higher incidence and mortality levels across multiple cancer types.
Yet, their stories are underrepresented in media and the top podcasts for cancer education do not feature Black experts.
We formed our podcast, The Onc Docs, to highlight the (under-told) stories of Black individuals with cancer and to provide education about cancer from Black patient survivors, patient advocates and oncologists.
We sought to understand the current landscape of podcasts focused on the Black cancer experience & to assess public engagement with The Onc Docs across social media platforms.
Methods: We conducted a search of "Black cancer" in Google, Spotify and Apple podcasts.
Search engines were also utilized to identify podcasts with a focus on the Black cancer experience.
Finally, we reviewed our publicly available listener and follower statistics.
Results: At least 12 podcasts on the Black cancer experience were identified with the majority available on Google Podcasts.
Seven of the twelve podcasts focused on breast cancer in Black women while two podcasts discussed prostate cancer and one featured brain tumors.
Two podcasts (17%) published episodes for one or more years.
The remaining podcasts (n = 10) were in existence for an average of 3 months.
Three podcasts had published an episode in 2022.
Since starting our podcast in September 2020, we have 958 Twitter followers and 400 followers on Instagram.
According to Spotify, from 2021-2022, our podcast was heard in 4 countries, increased 87% in streams, 40% in listeners and 235% in hours spent listening to our episodes.
On Google Podcasts, we have 4 subscribers.
Each month, about 100 unique visitors navigate to our website.
Conclusions: Podcasts on the Black cancer experience are needed especially those with a focus apart from breast cancer.
Prior podcasts may lack longevity due to a lack of financial and infrastructural support needed to sustain a podcast.
In the past year, our work has garnered attention from the general public and gained traction with patient advocacy and scientific associations like Black in Cancer, Cancer Research UK, and Touch Breast Cancer.
However, additional efforts & support are needed to ensure consistent creation and delivery of episodes.
For instance, we can utilize Facebook, the largest social media platform, to expand our reach.
With future growth, we will be able to access data analytic tools to determine the demographic breakdown of our audience and if we are reaching Black listeners.
Related Results
Survey results of patients with neuroendocrine cancer to find an overall high satisfaction with telemedicine and identify weaknesses of telemedicine unique to patients with rare cancers.
Survey results of patients with neuroendocrine cancer to find an overall high satisfaction with telemedicine and identify weaknesses of telemedicine unique to patients with rare cancers.
e16206 Background: The COVID-19 pandemic has presented significant challenges to healthcare providers; especially in the treatment of patients with cancer. Many centers have delay...
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Semaphorin3A increases M1-like microglia and retinal ganglion cell apoptosis after optic nerve injury
Semaphorin3A increases M1-like microglia and retinal ganglion cell apoptosis after optic nerve injury
Abstract
Background
The mechanisms leading to retinal ganglion cell (RGC) death after optic nerve injury have not been fully elucidated. Current evi...
Preparation of oxidized nanocellulose by using potassium dichromate
Preparation of oxidized nanocellulose by using potassium dichromate
Abstract
Nanocellulose (NC) derivatives are being used in a wide variety of high-quality functional applications. One of them is oxidized nanocellulose (ONC), which has bee...
Interactive Documentaries Informing Design
Interactive Documentaries Informing Design
The field of design research, thinking, and practice relies on various mediums and methods (Hanington, 2003) to improve the designs of products, services, and experiences. Even tho...
Best Intentions: Lessons Learned on International Partnering and Alliance Contracts
Best Intentions: Lessons Learned on International Partnering and Alliance Contracts
Abstract
Although the energy industry is still in the early stages of partnering and alliancing, there is enough accumulated experience to be worth sharing inform...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...

